Cancers (Jun 2023)

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)

  • Rosa Álvarez Álvarez,
  • Aránzazu Manzano,
  • Carolina Agra Pujol,
  • Vicente Artigas Raventós,
  • Raquel Correa,
  • Josefina Cruz Jurado,
  • Juan Angel Fernandez,
  • Xavier Garcia del Muro,
  • Jose Antonio Gonzalez,
  • Nadia Hindi,
  • Pablo Lozano Lominchar,
  • Javier Martínez-Trufero,
  • Ramiro Méndez,
  • Mercedes Muñoz,
  • Cristobal Muñoz Casares,
  • Francisco Orbis Castellanos,
  • Ruth Orellana Fernandez,
  • Miguel Paniagua González,
  • Andres Redondo,
  • Claudia Valverde Morales,
  • Jose Manuel Asencio

DOI
https://doi.org/10.3390/cancers15123194
Journal volume & issue
Vol. 15, no. 12
p. 3194

Abstract

Read online

Soft tissue sarcomas (STS) are an uncommon and biologically heterogeneous group of tumors arising from mesenchymal cells. The incidence is estimated at five cases per 100,000 people per year. Retroperitoneal sarcomas (RPS) account for 10–15% of all STS, and their management depends on their anatomical characteristics and histotype. Due to their very low incidence, it is recommended that RPS be treated in reference centers and evaluated by an experienced multidisciplinary team (MDT). In Spain, the Spanish Group for Research in Sarcomas (GEIS) brings together experts from various specialties to promote research on sarcomas and improve treatment results. This paper summarizes the GEIS recommendations for the diagnosis, treatment, and follow-up of patients with RPS.

Keywords